| | A European Strategy for Marine Biotechnology |
| | 0,55 | | MB |
| | 29 | | stron |
| | 1049 | | ID | ESF Marine Board, European Science Foundation |
| | 2001 | | rok |
| | Executive Summary 3 |
| | Key objectives 3 |
| | Implementation 3 |
| | Vision 4 |
| | European infrastructure and marine networks 4 |
| | Benefits from Marine Biotechnology 5 |
| | Developing novel drugs for treating disease 6 |
| | Producing diagnostic devices for monitoring health 8 |
| | Providing new techniques to monitor, assess, restore, protect and manage marine ecosystems 9 |
| | Ensuring safe and sustainable aquaculture and fisheries 10 |
| | Examples of the application of molecular genetics methodology to fisheries 12 |
| | Discovering new types of composite materials, biopolymers and enzymes for industry 12 |
| | Science and Technology Plan Objectives 14 |
| | Rationale 14 |
| | Objectives 15 |
| | Some potential areas for research and development 16 |
| | A European Strategy for Marine Biotechnology 16 |
| | A vision for marine biotechnology in the 21st century 17 |
| | Key Areas for Development in Europe 18 |
| | Bioprospecting/bioscreening for novel compounds 18 |
| | Genomics and proteomics of marine organisms 19 |
| | Biosensors for the assessment of environmental quality and management of marine environments |
| | 19 |
| | Study of fundamental biological processes in lower invertebrates 19 |
| | Development of new methods for the production of marine organisms 20 |
| | Safe and sustainable aquaculture 20 |
| | Appendices 22 |
| | 1. International Marine Biotechnology Initiatives 22 |
| | 2. Membership of the Feasibility Study Group (Marine Biotechnology) 27 |